Literature DB >> 33246591

Genomic Characterization of NSCLC in African Americans: A Step Toward "Race-Aware" Precision Medicine.

Hirva Mamdani1, Ann G Schwartz2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 33246591      PMCID: PMC8351353          DOI: 10.1016/j.jtho.2020.10.009

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  14 in total

1.  Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater.

Authors:  Martin Reck; Delvys Rodríguez-Abreu; Andrew G Robinson; Rina Hui; Tibor Csőszi; Andrea Fülöp; Maya Gottfried; Nir Peled; Ali Tafreshi; Sinead Cuffe; Mary O'Brien; Suman Rao; Katsuyuki Hotta; Kristel Vandormael; Antonio Riccio; Jing Yang; M Catherine Pietanza; Julie R Brahmer
Journal:  J Clin Oncol       Date:  2019-01-08       Impact factor: 44.544

Review 2.  Clinical Implications of Genomic Discoveries in Lung Cancer.

Authors:  Charles Swanton; Ramaswamy Govindan
Journal:  N Engl J Med       Date:  2016-05-12       Impact factor: 91.245

3.  Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer.

Authors:  Solange Peters; D Ross Camidge; Alice T Shaw; Shirish Gadgeel; Jin S Ahn; Dong-Wan Kim; Sai-Hong I Ou; Maurice Pérol; Rafal Dziadziuszko; Rafael Rosell; Ali Zeaiter; Emmanuel Mitry; Sophie Golding; Bogdana Balas; Johannes Noe; Peter N Morcos; Tony Mok
Journal:  N Engl J Med       Date:  2017-06-06       Impact factor: 91.245

4.  Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer.

Authors:  Shirish Gadgeel; Delvys Rodríguez-Abreu; Giovanna Speranza; Emilio Esteban; Enriqueta Felip; Manuel Dómine; Rina Hui; Maximilian J Hochmair; Philip Clingan; Steven F Powell; Susanna Yee-Shan Cheng; Helge G Bischoff; Nir Peled; Francesco Grossi; Ross R Jennens; Martin Reck; Edward B Garon; Silvia Novello; Belén Rubio-Viqueira; Michael Boyer; Takayasu Kurata; Jhanelle E Gray; Jing Yang; Tuba Bas; M Catherine Pietanza; Marina C Garassino
Journal:  J Clin Oncol       Date:  2020-03-09       Impact factor: 44.544

5.  STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.

Authors:  Ferdinandos Skoulidis; Michael E Goldberg; Danielle M Greenawalt; Matthew D Hellmann; Mark M Awad; Justin F Gainor; Alexa B Schrock; Ryan J Hartmaier; Sally E Trabucco; Laurie Gay; Siraj M Ali; Julia A Elvin; Gaurav Singal; Jeffrey S Ross; David Fabrizio; Peter M Szabo; Han Chang; Ariella Sasson; Sujaya Srinivasan; Stefan Kirov; Joseph Szustakowski; Patrik Vitazka; Robin Edwards; Jose A Bufill; Neelesh Sharma; Sai-Hong I Ou; Nir Peled; David R Spigel; Hira Rizvi; Elizabeth Jimenez Aguilar; Brett W Carter; Jeremy Erasmus; Darragh F Halpenny; Andrew J Plodkowski; Niamh M Long; Mizuki Nishino; Warren L Denning; Ana Galan-Cobo; Haifa Hamdi; Taghreed Hirz; Pan Tong; Jing Wang; Jaime Rodriguez-Canales; Pamela A Villalobos; Edwin R Parra; Neda Kalhor; Lynette M Sholl; Jennifer L Sauter; Achim A Jungbluth; Mari Mino-Kenudson; Roxana Azimi; Yasir Y Elamin; Jianjun Zhang; Giulia C Leonardi; Fei Jiang; Kwok-Kin Wong; J Jack Lee; Vassiliki A Papadimitrakopoulou; Ignacio I Wistuba; Vincent A Miller; Garrett M Frampton; Jedd D Wolchok; Alice T Shaw; Pasi A Jänne; Philip J Stephens; Charles M Rudin; William J Geese; Lee A Albacker; John V Heymach
Journal:  Cancer Discov       Date:  2018-05-17       Impact factor: 39.397

Review 6.  The evolving genomic classification of lung cancer.

Authors:  David S Shames; Ignacio I Wistuba
Journal:  J Pathol       Date:  2014-01       Impact factor: 7.996

7.  STK11 (LKB1) missense somatic mutant isoforms promote tumor growth, motility and inflammation.

Authors:  Paula Granado-Martínez; Sara Garcia-Ortega; Elena González-Sánchez; Kimberley McGrail; Rafael Selgas; Judit Grueso; Rosa Gil; Neia Naldaiz-Gastesi; Ana C Rhodes; Javier Hernandez-Losa; Berta Ferrer; Francesc Canals; Josep Villanueva; Olga Méndez; Sergio Espinosa-Gil; José M Lizcano; Eva Muñoz-Couselo; Vicenç García-Patos; Juan A Recio
Journal:  Commun Biol       Date:  2020-07-09

8.  Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer.

Authors:  Matthew D Hellmann; Luis Paz-Ares; Reyes Bernabe Caro; Bogdan Zurawski; Sang-We Kim; Enric Carcereny Costa; Keunchil Park; Aurelia Alexandru; Lorena Lupinacci; Emmanuel de la Mora Jimenez; Hiroshi Sakai; Istvan Albert; Alain Vergnenegre; Solange Peters; Konstantinos Syrigos; Fabrice Barlesi; Martin Reck; Hossein Borghaei; Julie R Brahmer; Kenneth J O'Byrne; William J Geese; Prabhu Bhagavatheeswaran; Sridhar K Rabindran; Ravi S Kasinathan; Faith E Nathan; Suresh S Ramalingam
Journal:  N Engl J Med       Date:  2019-09-28       Impact factor: 91.245

9.  Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.

Authors:  Jean-Charles Soria; Yuichiro Ohe; Johan Vansteenkiste; Thanyanan Reungwetwattana; Busyamas Chewaskulyong; Ki Hyeong Lee; Arunee Dechaphunkul; Fumio Imamura; Naoyuki Nogami; Takayasu Kurata; Isamu Okamoto; Caicun Zhou; Byoung Chul Cho; Ying Cheng; Eun Kyung Cho; Pei Jye Voon; David Planchard; Wu-Chou Su; Jhanelle E Gray; Siow-Ming Lee; Rachel Hodge; Marcelo Marotti; Yuri Rukazenkov; Suresh S Ramalingam
Journal:  N Engl J Med       Date:  2017-11-18       Impact factor: 91.245

10.  Whole-Exome Profiling of NSCLC Among African Americans.

Authors:  Rony F Arauz; Jung S Byun; Mayank Tandon; Sanju Sinha; Skyler Kuhn; Sheryse Taylor; Adriana Zingone; Khadijah A Mitchell; Sharon R Pine; Kevin Gardner; Eliseo J Perez-Stable; Anna M Napoles; Bríd M Ryan
Journal:  J Thorac Oncol       Date:  2020-09-12       Impact factor: 15.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.